You are currently viewing a new version of our website. To view the old version click .

3 Results Found

  • Article
  • Open Access
895 Views
22 Pages

Immunomodulatory Effects of High-Dose Irradiation Regimens in Renal Cell Carcinoma: Insights from an In Vitro Model with Human Peripheral Blood Mononuclear Cell

  • Fatima Meniai Merzouki,
  • Guillaume Paul Grolez,
  • Clément Bouchez,
  • Bertrand Leroux,
  • Jérôme Benoit,
  • Olivier Morales and
  • Nadira Delhem

Background: Stereotactic ablative radiotherapy (SABR) is increasingly used in the treatment of localized and metastatic renal cell carcinoma (RCC), a malignancy traditionally considered radioresistant. Beyond direct cytotoxicity, SABR may promote imm...

  • Article
  • Open Access
1 Citations
2,273 Views
18 Pages

Effects of Pre-Calving Body Condition and Different post partum Concentrate Feed Proportions on Immune-Associated and Hematological Parameters in Pluriparous Dairy Cows

  • Katharina Bünemann,
  • Jana Frahm,
  • Susanne Kersten,
  • Liane Hüther,
  • Ulrich Meyer,
  • Helga Sauerwein,
  • Jürgen Hummel,
  • Annette Zeyner and
  • Sven Dänicke

30 November 2020

The present study aimed at evaluating the influences of different concentrate feed proportions in the ration offered to dairy cows post partum with different body condition scores (BCS) before calving. Therefore, 60 pluriparous cows were divided 42 d...

  • Article
  • Open Access
17 Citations
3,762 Views
15 Pages

Circulating Neoplastic-Immune Hybrid Cells Predict Metastatic Progression in Uveal Melanoma

  • Michael S. Parappilly,
  • Yuki Chin,
  • Riley M. Whalen,
  • Ashley N. Anderson,
  • Trinity S. Robinson,
  • Luke Strgar,
  • Thomas L. Sutton,
  • Patrick Conley,
  • Christopher Klocke and
  • Summer L. Gibbs
  • + 4 authors

23 September 2022

Background: Uveal melanoma is an aggressive cancer with high metastatic risk. Recently, we identified a circulating cancer cell population that co-expresses neoplastic and leukocyte antigens, termed circulating hybrid cells (CHCs). In other cancers,...